Posicionamento científico | Recomendações para o uso da budesonida inalatória na COVID-19.
19 Jul, 2021 | 10:05hRecommendations for use of topical inhalant budesonide in COVID-19 – HNO
Relacionado: RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19 E Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19